Galanin in the regulation of the hypothalamic-pituitary-adrenal axis (Review)

被引:1
|
作者
Tortorella, Cinzia [1 ]
Neri, Giuliano [1 ]
Nussdorfer, Gastone G. [1 ]
机构
[1] Univ Padua, Sect Anat, Dept Human Anat & Physiol, I-35121 Padua, Italy
关键词
galanin; galanin receptors; hypothalamic-pituitary-adrenal axis; ACTH secretion; catecholamine secretion; glucocorticoid secretion; pituitary adenomas; pheochromocytomas; stress;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Galanin is a regulatory 30- or 29-amino acid peptide, widely distributed in the nervous system and gut, that acts via three subtypes of G protein-coupled receptors, named GAL-R I, GAL-R2 and GAL-R3. Findings have been accumulated that galanin regulates neuroendocrine hypothalamic axes, including the hypothalamic-pituitary-adrenal (HPA) one. Galanin and its receptors are expressed in the hypothalamic paraventricular and supraoptic nuclei, anterior pituitary and adrenal medulla. Adrenal cortex does not express galanin, but is provided with GAL-R1 and GAL-R2. The bulk of evidence indicates that galanin stimulates the activity of the central branch of the HPA axis (i.e. the release of corticotropin-releasing hormone and ACTH), thereby enhancing glucocorticoid secretion from the adrenal cortex. Investigations carried out in the rat show that galanin is also able to directly stimulate corticosterone (glucocorticoid) secretion from adrenocortical cells, through GAL-R1 and GAL-R2 coupled to the adenylate cyclase-protein kinase A signaling cascade, and nor-epinephrine release from adrenal medulla. There is indication that galanin may also enhance corticosterone release via an indirect paracrine mechanism involving the local release of catecholamines, which in turn activate B-adrenoceptors located on adrenocortical cells. The physiological relevance in the rat of the glucocorticoid secretagogue action of galanin is suggested by the demonstration that the blockade of galanin system significantly lowers basal corticosterone secretion. There is also evidence that galanin plays a role in the modulation of HPA-axis response to stress, as well as in the pathogenesis of pituitary adenomas and perhaps of pheochromocytomas.
引用
收藏
页码:639 / 647
页数:9
相关论文
共 50 条
  • [1] Regulation of the Hypothalamic-Pituitary-Adrenal Axis
    Papadimitriou, Anastasios
    Priftis, Kostas N.
    NEUROIMMUNOMODULATION, 2009, 16 (05) : 265 - 271
  • [2] Leptin and the regulation of the Hypothalamic-Pituitary-Adrenal axis
    Malendowicz, Ludwik K.
    Rucinski, Marcin
    Belloni, Anna S.
    Ziolkowska, Agnieszka
    Nussdorfer, Gastone G.
    INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 263, 2007, 263 : 63 - +
  • [3] Regulation of the hypothalamic-pituitary-adrenal axis by neuropeptides
    Aguilera, Greti
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2011, 7 (02) : 327 - 336
  • [4] Orexins in the regulation of the hypothalamic-pituitary-adrenal axis
    Spinazzi, R
    Andreis, PG
    Rossi, GP
    Nussdorfer, GG
    PHARMACOLOGICAL REVIEWS, 2006, 58 (01) : 46 - 57
  • [5] The Hypothalamic-Pituitary-Adrenal Axis and Anesthetics: A Review
    Besnier, Emmanuel
    Clavier, Thomas
    Compere, Vincent
    ANESTHESIA AND ANALGESIA, 2017, 124 (04): : 1181 - 1189
  • [6] HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    HONOUR, JW
    RESPIRATORY MEDICINE, 1994, 88 : 9 - 15
  • [7] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    FEEK, CM
    MARANTE, DJ
    EDWARDS, CRW
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1983, 12 (03): : 597 - 618
  • [8] REGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN DIABETES
    SCHWARTZ, MW
    STRACK, AM
    DALLMAN, MF
    DIABETES, 1995, 44 : A8 - A8
  • [9] NATRIURETIC PEPTIDES IN THE REGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    Porzionato, Andrea
    Macchi, Veronica
    Rucinski, Marcin
    Malendowicz, Ludwik K.
    De Caro, Raffaele
    INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 280, 2010, 280 : 1 - 39
  • [10] Genetic Approaches to Hypothalamic-Pituitary-Adrenal Axis Regulation
    Arnett, Melinda G.
    Muglia, Lisa M.
    Laryea, Gloria
    Muglia, Louis J.
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (01) : 245 - 260